FARAPULSE™ Pulsed Field Ablation (PFA) System

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

Paroxysmal Atrial FibrillationPersistent Atrial Fibrillation

Unknown Phase

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Active, not recruitingNCT06096337

Boston Scientific CorporationPersistent Atrial Fibrillation

Start: 2023-12-28End: 2028-02-04Updated: 2026-08-28

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

RecruitingNCT07444320

Boston Scientific CorporationParoxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Start: 2026-02-12End: 2028-02-01Target: 200Updated: 2026-08-28